• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

tom.witkowski@unimelb.edu.au

Credentials


Position
Research Assistant - Molecular Genetics
Department of Medicine
Education
Bachelors Degree (Honours)
The University of Melbourne
ORCID

0000-0003-1878-6104

Mr Tom Witkowski

Research Assistant - Molecular Genetics
Department of Medicine

22 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Pathogenic Variants in RNU2-2, a Non-coding Spliceosomal RNA, Cause a Distinctive Developmental and Epileptic Encephalopathy
    DOI: 10.1002/ana.78071
  • 2025

    Journal article

    T-Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B-Cell Lymphoma.
    DOI: 10.1002/jha2.70097
  • 2025

    Journal article

    Improving genetic diagnostic yield in familial and sporadic cerebral cavernous malformations: detection of copy number and deep Intronic variants
    DOI: 10.1093/hmg/ddaf077
  • 2023

    Conference Proceedings

    Somatic Variants Activating Ras-MAPK Signaling Cause a Spectrum of Focal Lesions Associated with Mesial Temporal Lobe Epilepsy
  • 2023

    Journal article

    Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy
    DOI: 10.1001/jamaneurol.2023.0473
  • 2023

    Journal article

    ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature
    DOI: 10.1007/s00428-022-03451-z
  • 2022

    Journal article

    Mosaicism in tuberous sclerosis complex: Lowering the threshold for clinical reporting
    DOI: 10.1002/humu.24454
Tom Witkowski

RECENT SCHOLARLY WORKS

  • 2022

    Conference Proceedings

    Hippocampal Somatic Mutations in Mesial Temporal Lobe Epilepsy
  • 2021

    Journal article

    A Synthetic DNA Construct to Evaluate the Recovery Efficiency of Cell-Free DNA Extraction and Bisulfite Modification
    DOI: 10.1093/clinchem/hvab095
  • 2021

    Conference Proceedings

    Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL): The RaDD Study.
    DOI: 10.1158/1538-7445.am2021-ct208

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224